Search

During a three-year study conducted at the Experimental Garden of the University of Warmia and Mazury in Olsztyn, the yield and quality of raspberry fruit of the summer-fruiting cultivars ‘Benefis’, ‘Laszka’ and the autumn-fruiting cultivars ‘Polesie’, ‘Polka’ and ‘Popiel’ were evaluated. The raspberry harvest was carried out on three carefully selected dates, i.e. for summer-fruiting cultivars: in the first, second and third decades of July and for autumn-fruiting cultivars in the second decade of August and the first and third decades of September. The highest yields were obtained from the cultivars ‘Polesie’ and ‘Polka’. The fruit of the tested cultivars collected during the third term had significantly lower masses. The highest contents of dry matter in fruit were recorded for ‘Polka’ and of organic acids for ‘Popiel’ and ‘Benefis’. The fruit harvested in the second and the third term had a higher content of dry matter.

The number of elderly patients requiring treatment of aortic stenosis is expected to grow steadily due to increasing lifespan. Transcatheter aortic valve implantation (TAVI) is an alternative treat‑ ment for patients with aortic stenosis considered nonoptimal candidates for surgical valve replacement.We aimed to assess age‑related differences in 30‑day and 1‑year cardiovascular mortality, Valve Academic Research Consortium‑2 (VARC‑2)-defined complications in patients undergoing TAVI, by comparing outcomes in patients younger than 85 years and those aged 85 years or older.The study group included patients who underwent TAVI at the Institute of Cardiology, Warsaw from January 2009 to July 2019. Clinical, procedural, and follow‑up data were retrospectively collected and compared in 2 groups defined according to age: group 1, younger than 85 years (417) and group 2, aged 85 or older (200).The surgical risk profile assessed by the EuroSCORE II was significantly higher in the group of older patients (median [interquartile range], 6.5% [3.5%-17.3%] vs 7.2% [3.4%-18.1%]; P = 0.002); 30‑day and 1‑year cardiovascular mortality was 4.3% in group 1 as compared with 5% in group 2 (P = 0.69) and 10.8% in group 1 as compared with 9.4% in group 2 (P = 0.51), respectively. The rate of VARC‑2‑defined complications was similar in both groups, with the exception of major vascular com‑ plications (3.12% vs 8.5%; P = 0.004) and major bleeding (10.8% vs 18.5%; P = 0.008), which were more prevalent in older patients.Cardiovascular mortality at 1 month and 1 year following TAVI is similar in patients aged 85 years or older and in those younger than 85 years.

INTRODUCTION The number of elderly patients requiring treatment of aortic stenosis is expected to grow steadily due to increasing lifespan. Transcatheter aortic valve implantation (TAVI) is an alternative treat‑ ment for patients with aortic stenosis considered nonoptimal candidates for surgical valve replacement. OBJECTIVES We aimed to assess age‑related differences in 30‑day and 1‑year cardiovascular mortality, Valve Academic Research Consortium‑2 (VARC‑2)-defined complications in patients undergoing TAVI, by comparing outcomes in patients younger than 85 years and those aged 85 years or older. PATIENTS AND METHODS The study group included patients who underwent TAVI at the Institute of Cardiology, Warsaw from January 2009 to July 2019. Clinical, procedural, and follow‑up data were retrospectively collected and compared in 2 groups defined according to age: group 1, younger than 85 years (417) and group 2, aged 85 or older (200). RESULTS The surgical risk profile assessed by the EuroSCORE II was significantly higher in the group of older patients (median [interquartile range], 6.5% [3.5%-17.3%] vs 7.2% [3.4%-18.1%]; P = 0.002); 30‑day and 1‑year cardiovascular mortality was 4.3% in group 1 as compared with 5% in group 2 (P = 0.69) and 10.8% in group 1 as compared with 9.4% in group 2 (P = 0.51), respectively. The rate of VARC‑2‑defined complications was similar in both groups, with the exception of major vascular com‑ plications (3.12% vs 8.5%; P = 0.004) and major bleeding (10.8% vs 18.5%; P = 0.008), which were more prevalent in older patients. CONCLUSION Cardiovascular mortality at 1 month and 1 year following TAVI is similar in patients aged 85 years or older and in those younger than 85 years.

In a four-year field experiment, fenhexamid, iprodione, pyrimethanil and thiram were applied in four different series as fungicides recommended for the control of grey mold (Botrytis cinerea) in strawberries. The plant protection products had no significant effect on the chemical composition of strawberry fruits of the Kent and Senga Sengana cultivars with the exception of an increase in the vitamin C level in ‘Kent’ strawberries. They also contributed to minor variations in the content of extract, total sugars, organic acids, polyphenols and anthocyanins. Dithiocarbamate residues were detected in all samples from the first harvest of strawberries that had been treated with the thiram fungicide